Recon Conformis, Inc. Appoints James Paiva as its new Vice President of U.S. Marketing; Inducement Grant Reported byJosh SandbergNovember 8, 2021
Recon Conformis, Inc. Announces Strong Clinical Study Results for Its Personalized Knee Implants byJosh SandbergSeptember 30, 2021
Recon Top Stories Conformis, Inc. Announces First Procedure Performed Using the Identity Imprint™ Knee Replacement System byJosh SandbergAugust 19, 2021
Recon Conformis, Inc. Announces Exclusive Distribution Agreement in China byJosh SandbergJune 23, 2021
Recon Orthopaedic Surgeon, Dr. Robert Snyder, performs the first outpatient Total Knee Arthroplasty using the Conformis iTotal G2 Patient-Specific Knee Replacement Prosthesis and Cutting Jigs byChris StewartMay 5, 2021
Recon Regulatory Conformis, Inc. Announces Clearance in Australia for iTotal® PS, the Only Personalized, Posterior-Stabilized Total Knee Replacement System byJosh SandbergMarch 2, 2021
Recon Conformis Announces U.S. Commercial Launch of Cordera™ Match Hip System byJosh SandbergDecember 17, 2020
Recon Regulatory Conformis Announces 510(k) Clearance for Cordera™ Hip System byJosh SandbergSeptember 29, 2020
Financial Recon Conformis Announces Farzin Khaghani as VP, US Marketing; Inducement Grants Reported byJosh SandbergAugust 14, 2020
Financial Conformis Reports Preliminary Second Quarter Revenue Results, Amendment to Credit Agreement byChris StewartJuly 6, 2020
